1、PRESS RELEASEOccidental Announces 4th Quarter 2025 Results Strengthened the balance sheet with the completion of the OxyChem sale on January 2,2026,reducing debt by$5.8 billion since mid-December 2025 and bringing principal debt to date to$15.0 billion Increased quarterly dividend by more than 8%to$
2、0.26 per share,payable April 15,2026,to stockholders of record as of March 10,2026;quarterly dividend per share has doubled in the last four years Strong operational performance drove operating cash flow of$2.6 billion and operating cash flow before working capital of$2.7 billion Capital spending in
3、cluding discontinued operations of$1.8 billion and contributions from noncontrolling interest of$47 million resulted in quarterly free cash flow before working capital of$1.0 billion Total company production of 1,481 Mboed exceeded the high end of guidance Midstream and marketing pre-tax adjusted in
4、come exceeded the high end of guidance Worldwide year-end proved reserves of 4.6 billion BOE with all-in reserves replacement ratio of 98%and organic reserves replacement ratio of 107%HOUSTON February 18,2026 Occidental(NYSE:OXY)today announced a net loss attributable to common stockholders of$68 mi
5、llion,or$0.07 per diluted share,and adjusted income attributable to common stockholders of$315 million,or$0.31 per diluted share,for the fourth quarter of 2025.The difference between net loss attributable to common stockholders and adjusted income attributable to common stockholders is mainly compri
6、sed of charges and transaction costs related to the sale of OxyChem.“Our emphasis on operational excellence and cost efficiency drove meaningful production and operating expense outperformance during the fourth quarter,”said President and Chief Executive Officer Vicki Hollub.“The quality of our asse